UsingCaenorhabditis elegansfor antimicrobial drug discovery

The Model Caenorhabditis elegans in Diabetes Mellitus and Alzheimer's Disease

(2017) Michael Morcos et al.   JOURNAL OF ALZHEIMERS DISEASE

Characterization of Plant-Derived Saponin Natural Products againstCandida albicans

(2010) Jeffrey J. Coleman et al.   ACS Chemical Biology

99th Dahlem Conference on Infection, Inflammation and Chronic Inflammatory Disorders: Caenorhabditis elegans as a model to study tissues involved in host immunity and microbial pathogenesis

(2010) J. E. Irazoqui et al.   CLINICAL AND EXPERIMENTAL IMMUNOLOGY

A predictive model for drug bioaccumulation and bioactivity in Caenorhabditis elegans

(2010) Andrew R Burns et al.   Nature Chemical Biology

Anthelmintic activity of KSI-4088 against Caenorhabditis elegans

(2010) Kusuma Kaewintajuk et al.   PARASITOLOGY RESEARCH

Automated High-Content Live Animal Drug Screening Using C. elegans Expressing the Aggregation Prone Serpin α1-antitrypsin Z

(2010) Sager J. Gosai et al.   PLoS One

A high-throughput method for assessing chemical toxicity using a Caenorhabditis elegans reproduction assay

(2010) Windy A. Boyd et al.   TOXICOLOGY AND APPLIED PHARMACOLOGY

High-Throughput Screen for Novel Antimicrobials using a Whole Animal Infection Model

(2009) Terence I. Moy et al.   ACS Chemical Biology

Antifungal Innate Immunity in C. elegans: PKCδ Links G Protein Signaling and a Conserved p38 MAPK Cascade

(2009) Katja Ziegler et al.   Cell Host & Microbe

The Tangled Web of Signaling in Innate Immunity

(2009) Jeffrey J. Coleman et al.   Cell Host & Microbe

Antifungal Drug Discovery through the Study of Invertebrate Model Hosts

(2009) R. Pukkila-Worley et al.   CURRENT MEDICINAL CHEMISTRY

C. elegans as Model for the Study of High Glucose- Mediated Life Span Reduction

(2009) A. Schlotterer et al.   DIABETES

Candida albicansHyphal Formation and Virulence Assessed Using aCaenorhabditis elegansInfection Model

(2009) Read Pukkila-Worley et al.   EUKARYOTIC CELL

Fungal echinocandin resistance

(2009) Louise A. Walker et al.   FUNGAL GENETICS AND BIOLOGY

Protein Kinase D Is an Essential Regulator of C. elegans Innate Immunity

(2009) Min Ren et al.   IMMUNITY

Evolutionarily conserved recognition and innate immunity to fungal pathogens by the scavenger receptors SCARF1 and CD36

(2009) Terry K. Means et al.   JOURNAL OF EXPERIMENTAL MEDICINE

A C. elegans-based, whole animal, in vivo screen for the identification of antifungal compounds

(2009) Emmanouil Tampakakis et al.   Nature Protocols

Medium- and high-throughput screening of neurotoxicants using C. elegans

(2009) Windy A. Boyd et al.   NEUROTOXICOLOGY AND TERATOLOGY

WormBase: a comprehensive resource for nematode research

(2009) Todd W. Harris et al.   NUCLEIC ACIDS RESEARCH

Identification of Antifungal Compounds Active against Candida albicans Using an Improved High-Throughput Caenorhabditis elegans Assay

(2009) Ikechukwu Okoli et al.   PLoS One

Identification of a CREB-dependent serotonergic pathway and neuronal circuit regulating foraging behavior inCaenorhabditis elegans: A useful model for mental disorders and their treatments?

(2008) George S. Zubenko et al.   AMERICAN JOURNAL OF MEDICAL GENETICS PART B-NEUROPSYCHIATRIC GENETICS

Acinetobacter baumannii: Emergence of a Successful Pathogen

(2008) A. Y. Peleg et al.   CLINICAL MICROBIOLOGY REVIEWS

DAF-16-Dependent Suppression of Immunity During Reproduction in Caenorhabditis elegans

(2008) S. Miyata et al.   GENETICS

Role for  -catenin and HOX transcription factors in Caenorhabditis elegans and mammalian host epithelial-pathogen interactions

(2008) J. E. Irazoqui et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Prokaryote-eukaryote interactions identified by using Caenorhabditis elegans

(2008) A. Y. Peleg et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA